Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

The only causative treatment for IgE-mediated allergies is allergen-specific immunotherapy. However, fewer than 5% of allergy patients receive immunotherapy because of its long duration and risk of allergic side effects. We aimed at enhancing s.c. immunotherapy by direct administration of allergen i...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Senti, Gabriela, Prinz Vavricka, Bettina M., Erdmann, Iris, Diaz, Mella I., Markus, Richard, McCormack, Stephen J., Simard, John J., Wüthrich, Brunello, Crameri, Reto, Graf, Nicole, Johansen, Pål, Kündig, Thomas M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: National Academy of Sciences 2008
Onderwerpen:
Biological Sciences
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2582048/
https://ncbi.nlm.nih.gov/pubmed/19001265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0803725105
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items